ERCC1 and response to chemotherapy

被引:0
|
作者
Soria, J. -C. [1 ]
机构
[1] Inst Gustave Roussy, Villejuif, France
来源
EJC SUPPLEMENTS | 2007年 / 5卷 / 08期
关键词
D O I
10.1016/S1359-6349(08)70029-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:15 / 15
页数:1
相关论文
共 50 条
  • [1] Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
    Steffensen, K. D.
    Waldstrom, M.
    Jeppesen, U.
    Brandslund, I.
    Jakobsen, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (04) : 702 - 710
  • [2] Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
    Waldstrom, M.
    Steffensen, K. D.
    Jeppesen, U.
    Brandslund, I.
    Jakobsen, A.
    [J]. APMIS, 2008, 116 (03) : 239 - 240
  • [3] Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
    Steffensen, K. D.
    Waldstrom, M.
    Jeppesen, U.
    Brandslund, I.
    Jakobsen, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Investigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma
    Zhang, Q.
    Lv, L. Y.
    Li, B. J.
    Zhang, J.
    Wei, F.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03) : 11235 - 11241
  • [5] Study on the ERCC1 gene polymorphism response to chemotherapy and prognosis of gastric cancer
    Liu, L.
    Li, C. H.
    Jin, T. F.
    Xu, D. Y.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2014, 13 (04) : 8722 - 8728
  • [6] Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma
    Cao, Z. H.
    Yin, H. P.
    Jiang, N.
    Yu, B.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03) : 10145 - 10151
  • [7] Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
    Braghiroli, M.
    Dib, L.
    Miranda, V.
    Siqueira, S.
    Hoff, P. M.
    Riechelmann, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S627 - S628
  • [8] Customizing chemotherapy in thoracic malignancies based on ERCC1 expression
    Sorensen, Jens Benn
    Jakobsen, Jan Nyrop
    Zimling, Zarah
    Wallerek, Sandra
    Vilmar, Adam
    [J]. LUNG CANCER MANAGEMENT, 2013, 2 (04) : 295 - 307
  • [9] ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting
    Kim, Chee Young
    Seo, Sang Hyuk
    An, Min Sung
    Kim, Kwang Hee
    Bae, Ki Beom
    Hwang, Jin Won
    Kim, Ji Hyun
    Kim, Bo Mi
    Kang, Mi Seon
    Oh, Min Kyung
    Hong, Kwan Hee
    [J]. ANNALS OF COLOPROCTOLOGY, 2015, 31 (03) : 92 - 97
  • [10] Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy
    Lu, Zheng-mao
    Luo, Tian-hang
    Nie, Ming-ming
    Fang, Guo-en
    Ma, Li-ye
    Xue, Xu-chao
    Wei, Guo
    Ke, Chong-we
    Bi, Jian-wei
    [J]. TUMOR BIOLOGY, 2014, 35 (04) : 2941 - 2948